Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles
Journal
Fertility and Sterility
Journal Volume
86
Journal Issue
4
Pages
1020-1022
Date Issued
2006
Author(s)
Abstract
The patients undertaking a single-dose protocol for GnRH antagonist were associated with elevated serum and follicular levels of nitric oxide (NO) and decreased embryo quality scores compared with those who underwent the long protocol for GnRH agonist. The relatively poor embryo quality may be NO related instead of Fas related. ? 2006 American Society for Reproductive Medicine.
SDGs
Other Subjects
cetrorelix; gonadorelin antagonist; nitric oxide; apoptosis; article; embryo development; enzyme linked immunosorbent assay; fertilization in vitro; nonhuman; priority journal; quality control; Dose-Response Relationship, Drug; Embryo; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nitric Oxide; Ovarian Follicle
Type
journal article